Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant:: tianeptine

被引:86
作者
McEwen, BS
Olié, JP
机构
[1] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10021 USA
[2] Hop St Anne, Univ Dept Psychiat, F-75674 Paris, France
关键词
tianeptine; depression; anxiety; neuroplasticity; hippocampus; amygdala;
D O I
10.1038/sj.mp.4001648
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Recent studies have provided evidence that structural remodeling of certain brain regions is a feature of depressive illness, and the postulated underlying mechanisms contribute to the idea that there is more to antidepressant actions that can be explained exclusively by a monoaminergic hypothesis. This review summarizes recent neurobiological studies on the antidepressant, tianeptine ( S-1574, [3-chloro-6-methyl-5,5-dioxo-6,11-dihydro-(c, f)-dibenzo( 1,2-thiazepine)-11-yl) amino]-7 heptanoic acid, sodium salt), a compound with structural similarities to the tricyclic antidepressant agents, the efficacy and good tolerance of which have been clearly established. These studies have revealed that the neurobiological properties of tianeptine involve the dynamic interplay between numerous neurotransmitter systems, as well as a critical role of structural and functional plasticity in the brain regions that permit the full expression of emotional learning. Although the story is far from complete, the schema underlying the effect of tianeptine on central plasticity is the most thoroughly studied of any antidepressants. Effects of tianeptine on neuronal excitability, neuroprotection, anxiety, and memory have also been found. Together with clinical data on the efficacy of tianeptine as an antidepressant, these actions offer insights into how compounds like tianeptine may be useful in the treatment of neurobiological features of depressive disorders.
引用
收藏
页码:525 / 537
页数:13
相关论文
共 123 条
[1]
Åberg MAI, 2000, J NEUROSCI, V20, P2896
[2]
Alby J M., 1993, Ann Psychiatry, V8, P136
[3]
AN ANALYSIS OF THE ORIGINS OF THE CHOLINERGIC AND NONCHOLINERGIC SEPTAL PROJECTIONS TO THE HIPPOCAMPAL-FORMATION OF THE RAT [J].
AMARAL, DG ;
KURZ, J .
JOURNAL OF COMPARATIVE NEUROLOGY, 1985, 240 (01) :37-59
[4]
Ansseau M, 1996, HUM PSYCHOPHARM CLIN, V11, P293
[5]
AUDINAT E, 2001, SOC NEUR ABSTR, V27
[6]
Volumetric brain imaging findings in mood disorders [J].
Beyer, JL ;
Krishnan, KRR .
BIPOLAR DISORDERS, 2002, 4 (02) :89-104
[7]
Reduced volume of orbitofrontal cortex in major depression [J].
Bremner, JD ;
Vythilingam, M ;
Vermetten, E ;
Nazeer, A ;
Adil, J ;
Khan, S ;
Staib, LH ;
Charney, DS .
BIOLOGICAL PSYCHIATRY, 2002, 51 (04) :273-279
[8]
Brion S, 1996, PRESSE MED, V25, P461
[9]
The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: A comparison with tianeptine [J].
Burghardt, NS ;
Sullivan, GM ;
McEwen, BS ;
Gorman, JM ;
LeDoux, JE .
BIOLOGICAL PSYCHIATRY, 2004, 55 (12) :1171-1178
[10]
CAMPBELL AM, 2003, SOC NEUROSCI, V833, P3